Anne Bass, MD
Enriched profileAttending Physician, Division of Rheumatology · Hospital for Special Surgery
Anne Bass is Attending Physician, Division of Rheumatology at Hospital for Special Surgery. OpenAlex indexes 165 publications with 4,181 citations (h-index 32); ClinicalTrials.gov lists 1 registered study with this person as an investigator.
Data verified 18 Nov 2026
Overview
Updated 20 Nov 2026
Anne Bass, MD, is Attending Physician, Division of Rheumatology at Hospital for Special Surgery. The public record shows 165 publications with 4,181 citations (h-index 32), centered on Rheumatoid Arthritis Research and Therapies, Cancer Immunotherapy and Biomarkers, Total Knee Arthroplasty Outcomes. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 4 companies, 1 NIH-funded awards (2025–2025).
- Most recent indexed publication: 2026 · Arthritis care & research
- Top research focus: Rheumatoid Arthritis Research and Therapies
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 4 companies
Generated from the cited public record · current as of 20 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 32 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 64.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on recordContact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 18 Nov 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Pilot Study of Atorvastatin for Orthopedic Surgery Patients
Sponsor: Hospital for Special Surgery, New York
Industry payments
Updated 18 Nov 2026
4 companies reported payments to CMS in program years 2022–2023. These are public disclosures, not judgments. The latest:
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment$36
- Celltrion USA Inc.Program year20231 payment$22
- GlaxoSmithKline, LLC.Program year20222 payments$46
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
37.5%Corticosteroid32.7%Prednisone100%Part D≥78 patientsAntidiarrheal microorganisms2.5%Folic Acid100%Part D≥12 patients+ 2 more classes in this area
Cancer & immunology
25%Folate Analog Metabolic Inhibitor14.4%Methotrexate100%Part D≥43 patientsTNF inhibitor3.9%Humira(Cf) Pen37%Simponi34%Enbrel29%Part D<11 patients+ 5 more classes in this area
Antiparasitic
12.6%Antimalarial12.6%Hydroxychloroquine Sulfate100%Part D≥35 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Nov 2026
1 NIH research award on record, funded 2025–2025 per NIH RePORTER. The latest:
- Circulating cell free tumor DNA (ctDNA) in patients with immune checkpoint inhibitor associated inflammatory arthritis (ICI-IA): developing a biomarker to assess immunosuppressive drug safety
Hospital for Special Surgery
FY2025$267,423R01AR085258
Congress activity
Updated 18 Nov 2026
16 congress contributions (2016–2025) across EULAR, SITC per OpenAlex. The most recent:
- POS0432 USE OF APREMILAST FOR THE TREATMENT OF IMMUNE CHECKPOINT INHIBITOR-INDUCED PSORIASIS AND PSORIATIC ARTHRITIS
EULAR Congress
EULAR2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 18 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Methodological Considerations in ICI-Myositis Research: Immortal Time Bias and Diagnostic Standardization.
Arthritis care & research
Letter2026 - Immune Checkpoint Inhibitor-Associated Inflammatory Arthritis.
Arthritis & rheumatology (Hoboken, N.J.)
Review2026 - Are Glucocorticoids Associated With Worse Survival Among Patients With Rheumatoid Arthritis and Lung Cancer Treated With Immune Checkpoint Inhibitors?
Arthritis & rheumatology (Hoboken, N.J.)
Article2026 - Arthroplasty Joint Histology and Surgical Outcomes in Patients on Immune Checkpoint Inhibitors: A Single-Center Case Series.
The Journal of rheumatology
Letter2026 - Use of Apremilast for the Treatment of Immune Checkpoint Inhibitor Psoriasis and Psoriatic Arthritis.
Arthritis care & research
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03
- 04
- 05Integration of Genetic, Clinical, and INR Data to Refine Warfarin DosingArticle216 citations2010
Network
Updated 18 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/anne-bass-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - ResearchGate
researchgate.net/profile/Anne-Bass
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- LinkedIn
linkedin.com/posts/hospital-for-special-surgery_a-new-study-by-hss-rheumatologist-dr-anne-activity-6318791548842713088-5QkF
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗ - Other
acr23.eventscribe.net/ajaxcalls/PresenterInfo.asp
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →acr23.eventscribe.net ↗ - Other
doctor.webmd.com/doctor/anne-bass-f6dc8906-e28e-446a-ad97-b71add8cc2b2-overview
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗ - Other
weillcornell.org/annerbass
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →weillcornell.org ↗ - Other
centerforbiosimilars.com/view/anne-bass-md-immune-checkpoint-inhibitors-in-rheumatic-disease
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →centerforbiosimilars.com ↗ - Other
hss.edu/profiles/doctors/anne-bass
- X / Twitter
x.com/HSpecialSurgery/status/1780295623956189637
- X / Twitter
x.com/HSpecialSurgery/status/2092948996079632474
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Medical degree
Columbia College of Physicians and Surgeons
Editorial & leadership roles
journal and society appointments- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rheumresearch.org ↗
- Board of Trustees
American College of Rheumatology
- Treasurer
American College of Rheumatology (ACR)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medicine.weill.cornell.edu ↗ - Chair
Committee on Training and Workforce
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →acr23.eventscribe.net ↗ - Rheumatology Fellowship Program Director
Hospital for Special Surgery
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →the-rheumatologist.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗
Secondary affiliations
appointments beyond the home institution- Professor of Medicine
Weill Cornell Medical College
Media & interviews
press, podcasts and appearances- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.hss.edu ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medscape.com ↗
- Article co-authored with Sang Kim
The Rheumatologist (immune checkpoint inhibitor-associated arthritis)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →the-rheumatologist.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Vivian Bykerk, MD
Hospital for Special Surgery
Robert Spiera, MD
Hospital for Special Surgery
Iris Navarro-Millan, MD
Hospital for Special Surgery
Teena Shetty, MD
Hospital for Special Surgery
David Felson, MD
Boston University
Marc Hochberg, MD
University of Maryland School of Medicine
Philip Mease, MD
Michelle Petri, MD
Johns Hopkins University School of Medicine